MDT vs RNTX · P/E 21, rev $36.36B vs $80.6M cap
Medtronic PLC (MDT) versus Rein Therapeutics Inc (RNTX) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. RNTX currently screens at market cap $80.6M.
Not investment advice. Open the MDT and RNTX stock pages for the full models.
Not investment advice.